Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.
Submitted on June 6, 2005
Accepted on July 14, 2005
Containing Pandemic Influenza at the Source
Ira M. Longini Jr 1*, Azhar Nizam 1, Shufu Xu 1, Kumnuan Ungchusak 2, Wanna Hanshaoworakul 2, Derek A. T. Cummings 3, Elizabeth M. Halloran 1
1 Department of Biostatistics, The Rollins School of Public Health, Emory University, 1518 Clifton Road, N.E., Atlanta, GA, USA. 2 Ministry of Public Health, Nonthaburi, Thailand. 3 Department of International Health, The Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD, USA.
* To whom correspondence should be addressed.
Ira M. Longini Jr , E-mail: longini{at}sph.emory.edu
Highly pathogenic avian influenza A (H5N1) is threatening ahuman pandemic of potentially devastating proportions. We usea stochastic influenza simulation model for rural South EastAsia to investigate the effectiveness of targeted antiviralprophylaxis, quarantine, and pre-vaccination in containing anemerging influenza strain at the source. If the basic reproductivenumber (R0) were below 1.60, our simulations show that a preparedresponse with targeted antivirals would have a high probabilityof containment. In this case, an antiviral agent stockpile onthe order of 100,000 to one million courses would be sufficient.If pre-vaccination occurs, then targeted antiviral prophylaxiscould be effective for containing strains with an R0 as highas 2.1. Combinations of targeted antiviral prophylaxis, pre-vaccinationand quarantine could contain strains with an R0 as high as 2.4.
The editors suggest the following Related Resources on Science sites:
In Science Magazine
LETTERS
Pui Hong Alex Chung;, Ira M. Longini Jr., and M. Elizabeth Halloran (18 November 2005) Science310 (5751), 1117c.
[DOI: 10.1126/science.310.5751.1117c] |Full Text »|PDF »
NEWS FOCUS
Martin Enserink (5 August 2005) Science309 (5736), 870.
[DOI: 10.1126/science.309.5736.870] |Summary »|Full Text »|PDF »
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
Threshold parameters for a model of epidemic spread among households and workplaces.
L. Pellis, N. M. Ferguson, and C. Fraser (2009)
J R Soc Interface
6, 979-987
|Abstract »|Full Text »|PDF »
Closing The Schools: Lessons From The 1918-19 U.S. Influenza Pandemic.
A. M. Stern, M. S. Cetron, and H. Markel (2009)
Health Aff.
28, w1066-w1078
|Abstract »|Full Text »|PDF »
Quantifying the Impact of Immune Escape on Transmission Dynamics of Influenza.
A. W. Park, J. M. Daly, N. S. Lewis, D. J. Smith, J. L. N. Wood, and B. T. Grenfell (2009)
Science
326, 726-728
|Abstract »|Full Text »|PDF »
The Transmissibility and Control of Pandemic Influenza A (H1N1) Virus.
Y. Yang, J. D. Sugimoto, M. E. Halloran, N. E. Basta, D. L. Chao, L. Matrajt, G. Potter, E. Kenah, and I. M. Longini Jr. (2009)
Science
326, 729-733
|Abstract »|Full Text »|PDF »
The role of population heterogeneity and human mobility in the spread of pandemic influenza.
Estimating Influenza Vaccine Efficacy From Challenge and Community-based Study Data.
N. E. Basta, M. E. Halloran, L. Matrajt, and I. M. Longini Jr. (2008)
Am. J. Epidemiol.
168, 1343-1352
|Abstract »|Full Text »|PDF »
Therapeutic Activity of an Anti-Idiotypic Antibody-Derived Killer Peptide against Influenza A Virus Experimental Infection.
G. Conti, W. Magliani, S. Conti, L. Nencioni, R. Sgarbanti, A. T. Palamara, and L. Polonelli (2008)
Antimicrob. Agents Chemother.
52, 4331-4337
|Abstract »|Full Text »|PDF »
Dynamic social networks and the implications for the spread of infectious disease.
J. M Read, K. T.D Eames, and W. J. Edmunds (2008)
J R Soc Interface
5, 1001-1007
|Abstract »|Full Text »|PDF »
Protecting residential care facilities from pandemic influenza.
M. Nuno, T. A. Reichert, G. Chowell, and A. B. Gumel (2008)
PNAS
105, 10625-10630
|Abstract »|Full Text »|PDF »
Individual space-time activity-based modelling of infectious disease transmission within a city.
Modeling targeted layered containment of an influenza pandemic in the United States.
M. E. Halloran, N. M. Ferguson, S. Eubank, I. M. Longini Jr., D. A. T. Cummings, B. Lewis, S. Xu, C. Fraser, A. Vullikanti, T. C. Germann, et al. (2008)
PNAS
105, 4639-4644
|Abstract »|Full Text »|PDF »
Pandemic lessons from Iceland.
S. F. Dowell and J. S. Bresee (2008)
PNAS
105, 1109-1110
|Full Text »|PDF »
Detecting Robust Patterns in the Spread of Epidemics: A Case Study of Influenza in the United States and France.
Analyzing Pathogen Transmission in the Dialysis Unit: Time for a (Schedule) Change?.
J. R. Hotchkiss, P. Holley, and P. S. Crooke (2007)
Clin. J. Am. Soc. Nephrol.
2, 1176-1185
|Abstract »|Full Text »|PDF »
The effect of population structure on the emergence of drug resistance during influenza pandemics.
F. Debarre, S. Bonhoeffer, and R. R Regoes (2007)
J R Soc Interface
4, 893-906
|Abstract »|Full Text »|PDF »
The impact of prophylaxis of healthcare workers on influenza pandemic burden.
M. Gardam, D. Liang, S. M Moghadas, J. Wu, Q. Zeng, and H. Zhu (2007)
J R Soc Interface
4, 727-734
|Abstract »|Full Text »|PDF »
Transmissibility of swine flu at Fort Dix, 1976.
J. Lessler, D. A.T Cummings, S. Fishman, A. Vora, and D. S Burke (2007)
J R Soc Interface
4, 755-762
|Abstract »|Full Text »|PDF »
Nonpharmaceutical Interventions Implemented by US Cities During the 1918-1919 Influenza Pandemic.
H. Markel, H. B. Lipman, J. A. Navarro, A. Sloan, J. R. Michalsen, A. M. Stern, and M. S. Cetron (2007)
JAMA
298, 644-654
|Abstract »|Full Text »|PDF »
Emergence of drug resistance: implications for antiviral control of pandemic influenza.
M. E Alexander, C. S Bowman, Z. Feng, M. Gardam, S. M Moghadas, G. Rost, J. Wu, and P. Yan (2007)
Proc R Soc B
274, 1675-1684
|Abstract »|Full Text »|PDF »
Conserved Surface Features Form the Double-stranded RNA Binding Site of Non-structural Protein 1 (NS1) from Influenza A and B Viruses.
C. Yin, J. A. Khan, G. V. T. Swapna, A. Ertekin, R. M. Krug, L. Tong, and G. T. Montelione (2007)
J. Biol. Chem.
282, 20584-20592
|Abstract »|Full Text »|PDF »
Media, Metaphors and Modelling: How the UK Newspapers Reported the Epidemiological Modelling Controversy during the 2001 Foot and Mouth Outbreak.
B. Nerlich (2007)
Science Technology Human Values
32, 432-457
|Abstract »|PDF »
Global Infectious Disease Surveillance And Health Intelligence.
Invited Commentary: Challenges of using Contact Data to Understand Acute Respiratory Disease Transmission.
M. E. Halloran (2006)
Am. J. Epidemiol.
164, 945-946
|Full Text »|PDF »
Using Data on Social Contacts to Estimate Age-specific Transmission Parameters for Respiratory-spread Infectious Agents.
J. Wallinga, P. Teunis, and M. Kretzschmar (2006)
Am. J. Epidemiol.
164, 936-944
|Abstract »|Full Text »|PDF »
Guillain-Barre Syndrome After Influenza Vaccination in Adults: A Population-Based Study..
D. N. Juurlink, T. A. Stukel, J. Kwong, A. Kopp, A. McGeer, R. E. Upshur, D. G. Manuel, R. Moineddin, and K. Wilson (2006)
Arch Intern Med
166, 2217-2221
|Abstract »|Full Text »|PDF »
Use of neuraminidase inhibitors to combat pandemic influenza.
J. Democratis, M. Pareek, and I. Stephenson (2006)
J. Antimicrob. Chemother.
58, 911-915
|Abstract »|Full Text »|PDF »
Key strategies for reducing spread of avian influenza among commercial poultry holdings: lessons for transmission to humans.
A. Le Menach, E. Vergu, R. F Grais, D. L Smith, and A. Flahault (2006)
Proc R Soc B
273, 2467-2475
|Abstract »|Full Text »|PDF »
Simple models for containment of a pandemic.
J. Arino, F. Brauer, P van den Driessche, J. Watmough, and J. Wu (2006)
J R Soc Interface
3, 453-457
|Abstract »|Full Text »|PDF »
Emergence of drug-resistant influenza virus: population dynamical considerations..